Bodhi Tree Biotechnology (BDTB) Net Cash Flow (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported Net Cash Flow of -$62038.0 for Q4 2025, up 4.96% year-over-year from -$59105.2 in Q4 2024, and down 513.51% quarter-over-quarter from -$10112.0 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) Net Cash Flow (2024 - 2025) Analysis & Trends
Bodhi Tree Biotechnology (BDTB) has 2 years of Net Cash Flow data on file, last reported at -$62038.0 in Q4 2025.
- Net Cash Flow for Q4 2025 came in at -$62038.0, up 4.96% year-over-year; the trailing twelve-month figure through Dec 2025 was -$146927.0 (changed N/A YoY), and the FY2025 annual result was -$150166.0, down 157.85% from the prior year.
- Net Cash Flow declined to -$62038.0 in Q4 2025 per BDTB's latest filing, from -$10112.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at -$10112.0 in Q3 2025 and troughed at -$65277.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -62,038.00 |
| Dec 31, 2025 | -62,038.00 |
| Sep 30, 2025 | -10,112.00 |
| Sep 30, 2025 | -10,112.00 |
| Jun 30, 2025 | -24,649.00 |
| Jun 30, 2025 | -24,649.00 |
| Mar 31, 2025 | -50,128.00 |
| Mar 31, 2025 | -50,128.00 |
| Dec 31, 2024 | -65,277.00 |
| Dec 31, 2024 | -65,277.00 |